Home Patent Forecast® Sectors Log In   Contact  

Pandemics/Epidemics (Free)


Vitaeris was a Vancouver based biopharmaceutical company that has since been acquired by the Pennsylvania based CSL Behring. The company focused on the development and application of the previously discovered IL-6 antibody, that was developed to treat autoimmune conditions, towards the field of kidney transplant rejections as well as developing other treatments and therapies with the antibody,

VITAERIS INC. Owned Patent Documents in this Patent Forecast
Loading Documents...